In castration-refractory prostate cancer, CTCs expressing kallikrein-related peptidase 3 mRNA were only detected in patients with a clinical diagnosis (through soft-tissue imaging and bone scans) of bone metastasis, which indicates that this peptidase can be used as an early bone metastatic detection [37]. Here, KLK3 is linked to bone metastasis.